Dr. Line Malha, MD

Dr. Malha practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Malha's NPI, 1124349949, was assigned on June 15, 2010. Dr. Malha graduated from American University of Beirut Faculty of Medicine in 2009. Dr. Malha's New York license number on file is 9294395.

Dr. Malha's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Malha's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Malha to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malha practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Malha's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Malha is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Malha's licenses on file in 2 states: New York and South Carolina.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Malha treats.

CMS data shows 513 Medicare services from Dr. Malha across 8 procedure codes in 2024, for 226 Medicare patients. Medicare paid $49,932 for them.

CMS counts 226 Medicare patients who saw Dr. Malha in 2024. The largest group is 75 to 84, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Malha's median patient age at 44, with 78% women.

In 2024, Dr. Malha wrote 528 Medicare Part D claims for 94 patients. 91% of them were for generic drugs. CMS names the drug for 375 of them, across 12 drugs with 11 or more claims each, at $28,335 in total drug cost. In 2023, CMS named 385 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Malha for performance year 2024, reported through an alternative payment model (APM). Dr. Malha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Malha as offering telehealth.

Dmand AI links 12 papers to Dr. Malha, published from 2015 to 2020. 2020 was the busiest year, with 3. The most frequent topics are Hypertension. Dr. Malha's most frequent co-authors are Phyllis August, MD, Darshana M. Dadhania, MD and John Richard Lee, MD.

Dmand AI links Dr. Malha to 1 clinical trial. Conditions studied include Pre-Eclampsia and Hypertension, Pregnancy-Induced.

Dr. Malha graduated from American University of Beirut Faculty of Medicine in 2009. Dr. Malha is a member of ASH, ASN, ISN and NKF.

Dr. Malha is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.